๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics (PK) of intravenous mycophenolate mofetil (MMF) in liver transplant patients.

โœ Scribed by Hebert, M.F.; Chang, T.; Linna, T.J.; Hale, M.D.; Roberts, J.P.

Book ID
110019663
Publisher
Nature Publishing Group
Year
1996
Tongue
English
Weight
178 KB
Volume
59
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of mycophenolic acid in
Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil
โœ Ashok Jain; Raman Venkataramanan; Tai Kwong; Ravi Mohanka; Mark Orloff; Peter Ab ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB

The bioavailability of mycophenolic acid (MPA) after oral administration of mycophenolate mofetil (MMF) has been reported to be more than 90% in healthy volunteers, and in kidney and thoracic organ transplant patients. Such information is limited in liver transplant (LTx) patients. The present study

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
โœ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req

A combination study design to examine my
A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients
โœ Hilal Maradit Kremers; Donnie P. Funch; Richard A. Robson; Michael A. Nalesnik; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 117 KB

Renal transplant recipients who are chronically immunosuppressed by drugs are at a higher risk of developing malignancies. Commonly observed malignancies are several forms of posttransplant lymphoproliferative disorders (PTLD), skin, lip and gynaecological cancers. The risk is associated with many r

Effect of T-tube clamping on the pharmac
Effect of T-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil
โœ Jain, Ashokkumar B. ;Hamad, Imad ;Zuckerman, Sheila ;Zhang, Shimin ;Warty, Vijay ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 116 KB ๐Ÿ‘ 1 views

The aim of the study was to evaluate the effect of t-tube clamping on the pharmacokinetics of mycophenolic acid (MPA) after oral administration of mycophenolate mofetil (MMF) in primary liver transplant recipients treated with tacrolimus as the primary immunosuppressive drug. We evaluated the pharma